MHRA: Microbiome Medicines Fall Under Existing UK Licensing Rules
As of 18 August 2026, no microbiome-based medicinal product held a UK marketing authorisation, the MHRA said. Some countries have authorised a small number of donor-derived microbiota products for C. difficile infection.





